Business Segments · Segment assets
Life Sciences and Emerging Growth Businesses — Segment assets
Corning Life Sciences and Emerging Growth Businesses — Segment assets decreased by 3.2% to $1.42B in Q1 2026 compared to the prior quarter.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026
Rolls up toAssets Net
How to read this metric
An increase indicates asset growth or expansion, while a decrease may suggest asset optimization or divestiture.
Detailed definition
This metric measures the total value of assets directly attributable to the Life Sciences and Emerging Growth segment, i...
Peer comparison
Comparable to segment asset reporting in diversified manufacturing firms.
Metric ID:
glw_segment_life_sciences_and_emerging_growth_businesses_segment_assetsHistorical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $1.47B | $1.42B |
| QoQ Change | — | -3.2% |
Range$1.42B – $1.47B
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Corning's life sciences and emerging growth businesses — segment assets?
- Corning (GLW) reported life sciences and emerging growth businesses — segment assets of $1.42B in Q1 2026.
- What does life sciences and emerging growth businesses — segment assets mean?
- The total value of assets used by the Life Sciences and Emerging Growth segment.